| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DBV TECHNOLOGIES | 249,600 | 9,068,000 | 0.55% | ||
| 52 | SPARK THERAPEUTICS INC | 150,000 | 9,009,000 | 0.55% | ||
| 53 | AIRCASTLE LTD | 428,600 | 8,512,000 | 0.52% | ||
| 54 | GW PHARMACEUTICALS PLC | 63,500 | 8,428,000 | 0.51% | ||
| 55 | XENCOR INC COM | 344,000 | 8,425,000 | 0.51% | ||
| 56 | KITE PHARMA INCORPORATED | 148,600 | 8,301,000 | 0.51% | ||
| 57 | TESLA INC | 40,000 | 8,161,000 | 0.50% | ||
| 58 | BLUEPRINT MEDICINES CORP COM | 265,000 | 7,871,000 | 0.48% | ||
| 59 | SAGE THERAPEUTICS | 170,000 | 7,829,000 | 0.48% | ||
| 60 | TESARO INC | 75,000 | 7,518,000 | 0.46% | ||
| 61 | PROTHENA CORP PLC | 120,000 | 7,196,000 | 0.44% | ||
| 62 | CASTLIGHT HEALTH INC COM CL B | 1,708,600 | 7,108,000 | 0.43% | ||
| 63 | BIOMARIN | 75,000 | 6,939,000 | 0.42% | ||
| 64 | ESSA Pharma | 2,719,410 | 6,828,000 | 0.42% | ||
| 65 | CERNER CORP | 108,200 | 6,681,000 | 0.41% | ||
| 66 | EXTRA SPACE STORAGE INC | 80,000 | 6,353,000 | 0.39% | ||
| 67 | NEUROCRINE BIOSCIE COM USD0.001 | 125,000 | 6,330,000 | 0.39% | ||
| 68 | CALPINE CORP | 500,000 | 6,320,000 | 0.39% | ||
| 69 | ULTRAGENYX PHARMACEUTICAL INC COM | 87,400 | 6,200,000 | 0.38% | ||
| 70 | ALNYLAM PHARMACEUTICALS INC | 90,000 | 6,100,000 | 0.37% | ||
| 71 | NOVAVAX INC COM | 2,179,700 | 4,534,000 | 0.28% | ||
| 72 | CEMPRA INC | 184,900 | 4,475,000 | 0.27% | ||
| 73 | TG THERAPEUTICS INC COM | 537,600 | 4,161,000 | 0.25% | ||
| 74 | Audentes Therapeutics, Inc. | 225,000 | 4,007,000 | 0.24% | ||
| 75 | COHERUS BIOSCIENCES INC COM | 145,000 | 3,883,000 | 0.24% | ||
| 76 | GLOBAL BLOOD THERAPEUTICS IN COM | 165,000 | 3,803,000 | 0.23% | ||
| 77 | INCYTE | 40,000 | 3,772,000 | 0.23% | ||
| 78 | VOYAGER THERAPEUTICS INC | 300,000 | 3,603,000 | 0.22% | ||
| 79 | ACLARIS THERAPEUTICS INC COM | 140,000 | 3,585,000 | 0.22% | ||
| 80 | Tracon Pharmaceuticals Inc | 517,700 | 3,500,000 | 0.21% | ||
| 81 | PROTEOSTASIS THERAPEUTICS IN | 220,000 | 3,430,000 | 0.21% | ||
| 82 | GALAPAGOS NV | 52,000 | 3,362,000 | 0.21% | ||
| 83 | REPLIGEN CORP COM | 110,000 | 3,321,000 | 0.20% | ||
| 84 | CIDARA THERAPEUTICS INC | 264,000 | 3,023,000 | 0.18% | ||
| 85 | VERTEX PHARMACEUT | 34,600 | 3,017,000 | 0.18% | ||
| 86 | NATUS MEDICAL INC. | 75,000 | 2,947,000 | 0.18% | ||
| 87 | ATRICURE INC | 180,000 | 2,848,000 | 0.17% | ||
| 88 | APPLIED GENETIC TECHNOL CORP | 279,100 | 2,730,000 | 0.17% | ||
| 89 | EPIZYME INC COM | 275,000 | 2,706,000 | 0.17% | ||
| 90 | JUNO THERAPEUTICS INCORPORATED | 90,000 | 2,701,000 | 0.16% | ||
| 91 | DYNAVAX TECHNOLOGIES CORP | 250,000 | 2,623,000 | 0.16% | ||
| 92 | CYTOMX THERAPEUTICS INC COM | 150,000 | 2,352,000 | 0.14% | ||
| 93 | TETRAPHASE PHARMACEUTICALS I COM | 600,000 | 2,298,000 | 0.14% | ||
| 94 | Dicerna Pharmaceuticals | 377,000 | 2,217,000 | 0.14% | ||
| 95 | SERES THERAPEUTICS INC | 178,200 | 2,190,000 | 0.13% | ||
| 96 | ONCOMED PHARMACEUTICALS INC | 190,000 | 2,172,000 | 0.13% | ||
| 97 | TANDEM DIABETES CARE INC | 275,000 | 2,107,000 | 0.13% | ||
| 98 | SYROS PHARMACEUTICALS INC | 150,000 | 2,081,000 | 0.13% | ||
| 99 | ACCURAY INCORPORATED COM | 306,200 | 1,950,000 | 0.12% | ||
| 100 | SPECTRA ENERGY PARTNERS LP | 32,000 | 1,398,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-16-000016, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
